The current status of small bowel transplantation in the UK and internationally

Gut

Volumn 54, Issue 11, 2005, Pages 1650-1657

  Middleton, S J ^a   Jamieson, N V ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADD ON THERAPY; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; DRUG TOLERANCE; ENTEROPATHY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTESTINE TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTE DEPLETION; MONOTHERAPY; NEUROLOGICAL COMPLICATION; ORGAN DONOR; PARENTERAL NUTRITION; PATIENT REFERRAL; PATIENT SELECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; SHORT BOWEL SYNDROME; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; TREATMENT OUTCOME; UNITED KINGDOM; VASCULAR ACCESS;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; INTESTINAL DISEASES; INTESTINE, SMALL; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 27444444033     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.062612     Document Type: Review

References (77)

1. Carrel A. The transplantation of organs. A preliminary communication. JAMA 1905;45:1645.
2. Okumura M, Mester M. The coming of age of small bowel transplantation: a historical perspective. Transplant Proc 1992;24:1241-2.
3. Calne RY, Rolles K, White DJG, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;2:1323-7.
4. Calne RY, White DJG, Thiru S, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaver organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;ii:1033-6.
5. Deterling R. Discussion. In: Alican F, Hardy JD, Cayrili M, et al. Intestinal transplantation: laboratory experience and report of a clinical case, Am Surg 1971;121:150.
6. Lilehei RC, Idezuki Y, Feemster JA, et al. Transplantation of stomach, intestine and pancreas: experimental and clinical observations. Surgery 1967;62:721.
7. Okumura M, Fujimura I, Ferrari A, et al. Transplante de intestine Delgado. Apresentacao de um caso. Rev Hosp Clin Fac Med S Paulo 1969;24:39.
8. Grant D, Wall W, Mineault R, et al. Successful small bowel/liver transplantation. Lancet 1990;335:181.
9. Starzl TE, Rowe M, Todo S, et al. Transplantation of multiple abdominal viscera. JAMA 1989;261:1449.
10. Williams J, Sankary H, Foster P, et al. Splanchnic transplantation: an approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA 1989;261:1458.
11. Goulet O, Sarnacki S. Isolated and combined liver-small bowel transplantation in Paris 1987-1995. Transplant Proc 1996;28:2750.
12. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995;222:270.
13. Starzl TE, Murase N, Demetris A, et al. Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 2004;77:926-9.
14. Cecka JM, Terasaki PI. World transplant records, Clinical Transplants 2001. Los Angeles: Los Angeles UCLA Immunogenetics Centre, 2002:279.
15. McGeown M, Douglas JF, Donaldson RA, et al. Ten year results of renal transplantation with azathioprine and prednisolone as only immunosuppression. Lancet 1998;1:983-5.
16. Starzl TE, Demetris AJ, Mirase N, et al. Cell migration, chimerism and graft acceptance. Lancet 1992;339:1579-82.
17. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-10.
18. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats. Transplantation 1995;60:158-71.
19. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis for graft acceptance. Hepatology 1993;17:1127-52.
20. Cortesini R, Suciu-Foca N. The concept of "partial" clinical tolerance. Transplant Immunol 2004;13:101-4.
21. Calne RY, Sells Ra, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-4.
22. Garcia D, Weppler D, Mittal S, et al. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004;36:323-4.
23. Fishbein TM, Florman S, Gondolesi G, et al. Intestinal transplantation before and after the introduction of sirolimus. Transplantation 2002;73:1538-42.
24. Messing, B Crenn P, Beau P, et al. Long term survival and parenteral nutrition dependence in adult patients with short bowel syndrome. Gastroenterology 1999;117:1043-50.
25. Jeppsen PB, Staun M, Mortensen PB. Adult patients receiving home parenteral nutrition in Denmark from 1991-1996: who will benefit form intestinal transplantation? Scand J Gastroenterl 1998;338:839-46.
26. Bozzefti F, Mariani L, Boggio Bertinet D. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100 000 catheter days. Clin Nutr 2002;21:475-85.
27. Buchman AL, Scolapio J, Fryer J. AGA Technical review on Short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1111-34.
28. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999;126:28-34.
29. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32.
30. Glencorse C, Meadows N, Holden C, et al. Trends in artificial nutritional support in fne UK Between 1996 and 2002, Report by the British Artificial Nutrition Survey (BANS). Secure Hold Business Centre, Redditch, Worcestershire: British Association for Parenteral and Enterai Nutrition (BAPEN), http://www.bapen.org.uk (accessed 22 August 2005).
31. Middleton SJ, Pollard S, Friend PJ, et al. Adult small intestinal transplantation in England and Wales. B J Surg 2003;90:723-727.
32. Intestinal Transplant Registry, 1985-2003. http://www. intestinaltransplant.org/(accessed 22 August 2005).
33. Harper AM, McBride MA, Ellison MD. The UNOS OPTN waiting list, 1988-1998. Clin Transpl 1999;9:71-82.
34. Fryer J, Pellar S, Ormond D, et al. Mortality in candidates waiting for combined liver intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl 2003;9:748-53.
35. The US Scientific Registry of Transplant Recipients and The Organ Procurement and Transplantation Network. Transplant data 1990-1999. 2000 Annual Report. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation and Richmond, VA, United Network of Organ Sharing..
36. Bueno J, Ohwada S, Kocoshis S, et al. Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatric Surg 1999;34:27-32.
37. American Gastroenterological Association. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology 2004;124:1105-10.
38. Kaufman SS, Atkinson JB, Biancni A, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001;5:80-7.
39. Scolapio SJ, Fleming CR, Kelly DG, et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clinic Proc 1999;74:217-22.
40. Kartzas T, Khan F, Tzakis AG. Clinical intestinal transplantation: Experience in Miami. Transplant Proc 1997;29:1787-9.
41. Pappas PA, Weppler D, Pinna AD, et al. Sirolimus in pediatric gastrointestinal transplantation: the use of sirolimus for pediatric transplant patients with tacrolimus related cardiomyopathy. Pediatr Transplant 2000;4:45-9.
42. Tzakis AG, Kato T, Nishida S, et al. Alematuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003;75:1512-17.
43. Abu-Elmagd K, Fung J, McGhee W, et al. The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc 2000;32:1195-6.
44. Farmer DG, McDiarmid SV, Yersiz H, et al. Outcomes after intestinal transplantation: a single-center experience over a decade. Transplant Proc 2002;34:896-7.
45. Goulet O, Lacaille F, Colomb V, et al. Intestinal transplantation in children: Paris experience. Transplant Proc 2002;34:1887-8.
46. Carreno MR, Kato T, Weppler D, et al. Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multi organ transplants. Transplant Proc 2001;33:1015-17.
47. Tzakis AG, Tryphonopoulos P, Kato T, et al. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation 2004;78:489.
48. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998;186:512-27.
49. Murase N, Ye Q, Lee RG. et al, Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc, 1999;31:565-6.
50. Shah SM, Roberts PJ, Watson G, et al. Relapsing encephalopathy following small bowel transplantation. Transplant Proc 2003;35:1565-6.
51. Calne RY, Friend PJ, Middleton S, et al. Intestinal transplant between two identical triplets. Lancet 1997;350:1077-8.
52. Sudan DL, Kaufman SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Castroenterol 2000;95:1506-15.
53. Pinna AD, Webbler D, Nevy J, et al. Intestinal transplanation at the University of Miami: five years of experience. Transplant Proc 2000;32:1226-7.
54. Goulet O, Jan D, Lacaille F, et al. Intestinal transplantation in children: preliminary experience in Paris. JPEN J Parenter Enteral Nutr 1999;23:S121-5.
55. DiMartini A, Giuseppe RM, Toby G, et al. Quality of life after small intestinal transplantation and amoung home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1998;22:357-62.
56. Cameron EAB, Binnie JAH, Jamieson NV, et al. Quality of life an adults following small bowel transplantation. Tranaplant Proc 2002;34:965-6.
57. Guiseppe RM, DiMartini A, Schoen RE, et al. Quality of life of patients after intestinal transplantation. Transplantation 1998;66:1141-5.
58. Abu-Elmagd K, Reyes J, Fung JJ, et al. Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc 1999;31:582-4.
59. Schalamon J, Mayr JM, Hollwarth ME, et al. Mortality and economics in short bowel syndrome. 2003;17:931-42.
60. Bryant JJ. Observations upon the growth and length of the human intestine. Am J Med Sci 1924;167:499-520.
61. Lee RG, Nakamura K, Tsamanda AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-34.
62. Sigurdsson L, Reyes J, Todos, et al. Anatomic variability of rejection in intestinal allograrts after pediatric intestinal transplantation. J Pediatr Gastroenterol Nutr 1998;27:403-6.
63. Sudan DL, Kaufman SS, Shaw BW Jr, et al: Isolated intestinal transplantation for intestinal failure.. Am J Gastroenterol 2000;95:1606-15.
64. Kusne S, Furukawa H, Abu EK, et al: Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996;28:2761-2.
65. Cicalese L, Sileri P, Green M, et al. Bacterial translocation in clinical intestinal transplantation. Transplant Proc 2000;32:1210.
66. Rajendra Prassad K, Pollard SG. Small bowel transplantation. Current Opin Gastroenterol 2000;16:126-33.
67. Office for National Statistics England and Wales. London: Office for National Statistics England and Wales, 2000, series DH2 No. 26: 134-9, ISBN 011 621383 3.ISSN 0265-9670.http://www.statistics.gov.uk (accessed 22 August 2005).
68. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplatation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999;354:1147-52.
69. Jacob M, Copley LP, Lewsey JD, et al. UK and Ireland liver transplant audit. London: Annual Report to the National Specialist Commissioning Advisory Group (NSCAG), 2004.
70. Taylor DO, Edwards LB, Boucek MM, et al. The registry for the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004;23:796-803.
71. Trulock EP, Edwards LB Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report. J Heart Lung Transplant 2004;23:804-15.
72. Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transplant Proc 1996;28:2691.
73. Chan WK, Friend PJ, Jamieson NV, et al. Multivisceral grafting for Gardener's syndrome. J Wound Care 1995;4:214-16.
74. Jeppesen PB, Mortensen PB. Enhancing bowel adaptation in short bowel syndrome. Curr Gastroenterol Rep 2002;4:338-47.
75. Jeppesen PB. Clinical significance of GLP-2 in short-bowel syndrome. J Nutr 2003;133:3721-4.
76. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004;240:748-54.
77. Day RM, Boccaccini AR, Shurey S, et al. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 2004;25:5857-66.